MedTrace Logo

Combating Diagnostic Wandering and Impasse for Cystic Fibrosis

NCT05654480 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 400

Last updated 2022-12-16

No results posted yet for this study

Summary

After cystic fibrosis (CF) neonatal screening, some children remain with a not concluded diagnosis. In France, the medical follow-up is not standardized, some of them may be lost of follow-up. The aim of the study is to identify children at risk of developing CF. Other children carry mutation at risk of CFTR related disorder (CFTR-RD) but remain asymptomatic during childhood. The aim of the study is to evaluate those children by microbiology, respiratory function test and lung imaging tests to reclassify them in the CFTR spectrum.

Conditions

Sponsors & Collaborators

  • Vaincre la Mucoviscidose

    collaborator OTHER

  • Societe Francaise de la Mucoviscidose

    lead OTHER

Principal Investigators

  • Christophe Marguet, MD · Societe Francaise de la Mucoviscidose

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-01-02
Primary Completion
2024-05-01
Completion
2024-12-31

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05654480 on ClinicalTrials.gov